(RTTNews) – Telix Pharmaceuticals Limited (TLX, TLX.AX) announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TLX101-Px (Pixclara, Floretyrosine F 18 or 18F-FET). This investigational PET imaging agent is intended to help